Key result
TYG-BMI between 250-275 linked to ~24% lower hospital mortality in critically ill HF patients.
Why the study?
The physiological meaning of TYG-BMI in critical illness remains uncertain, and its dynamic relationship with mortality in critically ill heart failure patients had not been investigated.
Does TYG-BMI demonstrate a time-dependent, non-linear association with hospital mortality in critically ill heart failure patients?
Cohort (n=5,133)
Yes
Does TYG-BMI demonstrate a time-dependent, non-linear association with hospital mortality in critically ill heart failure patients?
Effect estimate: OR 0.76 (95% CI 0.68-0.85)
p-value: p=<0.001
TYG-BMI exhibits a reproducible U-shaped association with hospital mortality in critically ill heart failure patients, and combining it with the SOFA score significantly improves mortality prediction.
Supports adding TYG-BMI to SOFA for improved mortality prediction in critically ill HF; leaves open causality and merits interventional trials.
The triglyceride-glucose-body mass index (TYG-BMI) is a surrogate marker of insulin resistance associated with cardiovascular outcomes in stable populations. However, its physiological meaning in critically ill patients—where glucose and triglyceride levels are influenced by acute stress, inflammation, and treatment—remains uncertain, and the dynamic relationship between TYG-BMI and mortality in critically ill heart failure (HF) patients has not been investigated. To examine the association between TYG-BMI intensity, exposure duration, and hospital mortality in critically ill HF patients, and to evaluate the robustness of these associations through comprehensive sensitivity analyses. This multicenter retrospective study analyzed data from MIMIC-III, MIMIC-IV, and eICU databases. Adult HF patients with daily TYG-BMI measurements during the 7 day observation period (day 0 through day 7) were included. Restricted cubic spline regression characterized the baseline dose–response relationship. Generalized additive models with tensor product smooth functions examined the three-dimensional TYG-BMI–time–mortality association. Weighted linear regression quantified temporal trends. Multiple sensitivity analyses addressed selection bias, time-varying confounding, treatment effect modification, and temporal heterogeneity. Among 5133 patients (pooled mortality: 27.9%), restricted cubic spline analysis confirmed a non-linear U-shaped dose–response relationship in MIMIC-IV (non-linear P < 0.001), with consistent directional patterns across MIMIC-III and eICU. Generalized additive models demonstrated a reproducible U-shaped association across all three databases. The optimal TYG-BMI range was 250–275 (OR = 0.76, 95% CI 0.68–0.85, P < 0.001 in MIMIC-IV), with each additional day within this range reducing mortality risk by 0.4% (P < 0.01). TYG-BMI > 425 was associated with progressively increased mortality (OR = 1.61, 95% CI 1.35–1.93 for the 425–450 range), with time-dependent risk amplification reaching 2.5% per day at the highest stratum. Combining TYG-BMI with the SOFA score significantly improved discriminative performance beyond SOFA alone (AUC: 0.780 versus 0.720, DeLong P < 0.001). All sensitivity analyses yielded consistent findings. TYG-BMI demonstrates a reproducible, U-shaped association with hospital mortality in critically ill HF patients. Both intensity and exposure duration contribute to risk stratification, though prospective validation is warranted given the observational design and uncertain physiological specificity of TYG-BMI in the ICU setting.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Heart failure in critically ill patients (n=5,133). Triglyceride-glucose-body mass index (TYG-BMI) optimal range (250-275) vs. TYG-BMI outside the 250-275 range (e.g., >425) was evaluated on Hospital mortality (OR 0.76, 95% CI 0.68-0.85, p=<0.001). Maintaining a triglyceride-glucose-body mass index (TYG-BMI) within the optimal range of 250-275 reduced the risk of hospital mortality (OR 0.76) in critically ill patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: